Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

I this qualitative study, Investigators will conduct semi-structured interviews with clinicians that are involved in the care of patients with breast cancer to evaluate the acceptability, appropriateness, and feasibility/usability of a metastatic breast cancer-specific prognostic tool. These interviews will be conducted by the UNC CHAI Core and will continue until thematic saturation (estimated 10 participants). The investigators will code the qualitative data using emerging themes, guided by a well-established implementation science theory, the Consolidated Framework for Implementation Research (CFIR). The information gained from these studies will inform an implementation approach to increase the usability and acceptability of a novel prognostic tool to assist oncologists in the prognosis of patients with metastatic breast cancer.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Ustna zgoda na udział w badaniu
  • Chęć i możliwość uczestniczenia w badaniu zgodnie z jego wymogami
  • Zatrudnienie jako lekarz, pielęgniarka, asystent lekarza lub pracownik ds. opieki nad pacjentami
  • Co najmniej 6 miesięcy doświadczenia w opiece nad pacjentami z zaawansowanym rakiem piersi w USA

✗ Disqualifies

  • Nie posługiwanie się językiem angielskim

Simplified criteria — AI translation

Trial details

Last updated (source)
September 24, 2025
Sex
No restrictions

Therapies / drugs in trial

Locations (1)

University of North Carolina

Chapel Hill, United States

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.